Different mechanisms of homologous and heterologous μ-opioid receptor phosphorylation

British Journal of Pharmacology

Volumn 172, Issue 2, 2015, Pages 311-316

  Mann, Anika ^a   Illing, Susann ^a   Miess, Elke ^a   Schulz, Stefan ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

analgesia; dephosphorylation; GRK; MOR; morphine; phosphorylation; PKC; tolerance

Indexed keywords

BETA ARRESTIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; G PROTEIN COUPLED RECEPTOR KINASE 2; G PROTEIN COUPLED RECEPTOR KINASE 3; G PROTEIN COUPLED RECEPTOR KINASE 5; GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE; MU OPIATE RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN KINASE C ALPHA; PROTEIN PHOSPHATASE 1GAMMA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

CELL MEMBRANE; DRUG TOLERANCE; ENDOSOME; HUMAN; INTERNALIZATION; NONHUMAN; OPIATE ADDICTION; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; AGONISTS; ANIMAL; METABOLISM; PHOSPHORYLATION;

ANIMALS; HUMANS; PHOSPHORYLATION; RECEPTORS, OPIOID, MU;

EID: 84920167257     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12627     Document Type: Review

References (48)

1. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, Peters JA, Harmar AJ, and CGTP Collaborators (2013). The Concise Guide to PHARMACOLOGY 2013/14: G-Protein Coupled Receptors. Br J Pharmacol 170: 1459-1581.
2. Atwood BK, Lopez J, Wager-Miller J, Mackie K, Straiker A, (2011). Expression of G protein-coupled receptors and related proteins in HEK293, AtT20, BV2, and N18 cell lines as revealed by microarray analysis. BMC Genomics 12: 14.
3. Bailey CP, Connor M, (2005). Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol 5: 60-68.
4. Bailey CP, Kelly E, Henderson G, (2004). Protein kinase C activation enhances morphine-induced rapid desensitization of mu-opioid receptors in mature rat locus ceruleus neurons. Mol Pharmacol 66: 1592-1598.
5. Bailey CP, Llorente J, Gabra BH, Smith FL, Dewey WL, Kelly E, et al. (2009). Role of protein kinase C and mu-opioid receptor (MOPr) desensitization in tolerance to morphine in rat locus coeruleus neurons. Eur J Neurosci 29: 307-318.
6. Chen C, Li J, Bot G, Szabo I, Rogers TJ, Liu-Chen LY, (2004). Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor. Eur J Pharmacol 483: 175-186.
7. Chen YJ, Oldfield S, Butcher AJ, Tobin AB, Saxena K, Gurevich VV, et al. (2013). Identification of phosphorylation sites in the COOH-terminal tail of the mu-opioid receptor. J Neurochem 124: 189-199.
8. Christie MJ, (2008). Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol 154: 384-396.
9. Connor M, Osborne PB, Christie MJ, (2004). Mu-opioid receptor desensitization: is morphine different? Br J Pharmacol 143: 685-696.
10. Corbett AD, Henderson G, McKnight AT, Paterson SJ, (2006). 75 years of opioid research: the exciting but vain quest for the Holy Grail. Br J Pharmacol 147 (Suppl. 1): S153-S162.
11. Doll C, Konietzko J, Poll F, Koch T, Hollt V, Schulz S, (2011). Agonist-selective patterns of micro-opioid receptor phosphorylation revealed by phosphosite-specific antibodies. Br J Pharmacol 164: 298-307.
12. Doll C, Poll F, Peuker K, Loktev A, Gluck L, Schulz S, (2012). Deciphering micro-opioid receptor phosphorylation and dephosphorylation in HEK293 cells. Br J Pharmacol 167: 1259-1270.
13. El Kouhen R, Burd AL, Erickson-Herbrandson LJ, Chang CY, Law PY, Loh HH, (2001). Phosphorylation of Ser363, Thr370, and Ser375 residues within the carboxyl tail differentially regulates mu-opioid receptor internalization. J Biol Chem 276: 12774-12780.
14. Feng B, Li Z, Wang JB, (2011a). Protein kinase C-mediated phosphorylation of the mu-opioid receptor and its effects on receptor signaling. Mol Pharmacol 79: 768-775.
15. Feng B, Li Z, Wang JB, (2011b). Protein kinase C-mediated phosphorylation of the mu-opioid receptor and its effects on receptor signaling. Mol Pharmacol 79: 768-775.
16. Ferguson SS, (2001). Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53: 1-24.
17. Ferguson SS, Caron MG, (1998). G protein-coupled receptor adaptation mechanisms. Semin Cell Dev Biol 9: 119-127.
18. Ferguson SS, Downey WE 3rd, Colapietro AM, Barak LS, Menard L, Caron MG, (1996). Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 271: 363-366.
19. Grecksch G, Just S, Pierstorff C, Imhof AK, Gluck L, Doll C, et al. (2011). Analgesic tolerance to high-efficacy agonists but not to morphine is diminished in phosphorylation-deficient S375A mu-opioid receptor knock-in mice. J Neurosci 31: 13890-13896.
20. Illing S, Mann A, Schulz S, (2013). Heterologous regulation of agonist-independent mu-opioid receptor phosphorylation by protein kinase C. Br J Pharmacol 171: 1330-1340.
21. Johnson EA, Oldfield S, Braksator E, Gonzalez-Cuello A, Couch D, Hall KJ, et al. (2006). Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells. Mol Pharmacol 70: 676-685.
22. Just S, Illing S, Trester-Zedlitz M, Lau EK, Kotowski SJ, Miess E, et al. (2013). Differentiation of opioid drug effects by hierarchical multi-site phosphorylation. Mol Pharmacol 83: 633-639.
23. Kelly E, Bailey CP, Henderson G, (2008). Agonist-selective mechanisms of GPCR desensitization. Br J Pharmacol 153 (Suppl. 1): S379-S388.
24. Koch T, Hollt V, (2008). Role of receptor internalization in opioid tolerance and dependence. Pharmacol Ther 117: 199-206.
25. Koob GF, Sanna PP, Bloom FE, (1998). Neuroscience of addiction. Neuron 21: 467-476.
26. Krupnick JG, Benovic JL, (1998). The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38: 289-319.
27. Lau EK, Trester-Zedlitz M, Trinidad JC, Kotowski SJ, Krutchinsky AN, Burlingame AL, et al. (2011). Quantitative encoding of the effect of a partial agonist on individual opioid receptors by multisite phosphorylation and threshold detection. Sci Signal 4: ra52.
28. Liu JG, Anand KJ, (2001). Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Brain Res Rev 38: 1-19.
29. McPherson J, Rivero G, Baptist M, Llorente J, Al-Sabah S, Krasel C, et al. (2010). Mu-opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization. Mol Pharmacol 78: 756-766.
30. Morgan MM, Christie MJ, (2011). Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human. Br J Pharmacol 164: 1322-1334.
31. Mouledous L, Froment C, Dauvillier S, Burlet-Schiltz O, Zajac JM, Mollereau C, (2012). GRK2 protein-mediated transphosphorylation contributes to loss of function of mu-opioid receptors induced by neuropeptide FF (NPFF2) receptors. J Biol Chem 287: 12736-12749.
32. Nestler EJ, (1996). Under siege: the brain on opiates. Neuron 16: 897-900.
33. Nestler EJ, Aghajanian GK, (1997). Molecular and cellular basis of addiction. Science 278: 58-63.
34. Nishizuka Y, (1992). Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614.
35. Peng PW, Sandler AN, (1999). A review of the use of fentanyl analgesia in the management of acute pain in adults. Anesthesiology 90: 576-599.
36. Pergolizzi J, Boger RH, Budd K, Dahan A, Erdine S, Hans G, et al. (2008). Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 8: 287-313.
37. Pfeiffer M, Koch T, Schroder H, Laugsch M, Hollt V, Schulz S, (2002). Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. J Biol Chem 277: 19762-19772.
38. Pfeiffer M, Kirscht S, Stumm R, Koch T, Wu D, Laugsch M, et al. (2003). Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization. J Biol Chem 278: 51630-51637.
39. Pitcher JA, Freedman NJ, Lefkowitz RJ, (1998). G protein-coupled receptor kinases. Annu Rev Biochem 67: 653-692.
40. Schulz S, Mayer D, Pfeiffer M, Stumm R, Koch T, Hollt V, (2004). Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375. EMBO J 23: 3282-3289.
41. Sibley DR, Lefkowitz RJ, (1985). Molecular mechanisms of receptor desensitization using the beta-adrenergic receptor-coupled adenylate cyclase system as a model. Nature 317: 124-129.
42. Waldhoer M, Bartlett SE, Whistler JL, (2004). Opioid receptors. Annu Rev Biochem 73: 953-990.
43. Whistler JL, Chuang HH, Chu P, Jan LY, von Zastrow M, (1999). Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23: 737-746.
44. Williams JT, Christie MJ, Manzoni O, (2001). Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81: 299-343.
45. Yu Y, Zhang L, Yin X, Sun H, Uhl GR, Wang JB, (1997). Mu opioid receptor phosphorylation, desensitization, and ligand efficacy. J Biol Chem 272: 28869-28874.
46. von Zastrow M, Svingos A, Haberstock-Debic H, Evans C, (2003). Regulated endocytosis of opioid receptors: cellular mechanisms and proposed roles in physiological adaptation to opiate drugs. Curr Opin Neurobiol 13: 348-353.
47. Zhang J, Ferguson SS, Barak LS, Bodduluri SR, Laporte SA, Law PY, et al. (1998). Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc Natl Acad Sci U S A 95: 7157-7162.
48. Zhang L, Yu Y, Mackin S, Weight FF, Uhl GR, Wang JB, (1996). Differential mu opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J Biol Chem 271: 11449-11454.